Clinical Trials Browser

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04104529 2026-06-04

BCB RIV

Phase NA Recruiting

350 enrolled

EndocrineGenitourinaryHead & NeckNET

Prostatic Neoplasms, Thyroid Neoplasms, Neuroendocrine Tumors

NCT04339036 2026-06-04

CapTemY90

Phase 2 Recruiting

70 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT04954820 2026-06-04

ReLUTH

Phase 2 Recruiting

146 enrolled

EndocrineNET

Neuroendocrine Tumors, Disease Progression

NCT06607692 2026-06-04

LUPARPED

Phase 1/2 Recruiting

25 enrolled

CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT07612748 2026-06-03

Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms

Phase NA Recruiting

483 enrolled

EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

NCT07621146 2026-06-02

NET-COMPARE

Not yet recruiting

51 enrolled

CNSEndocrineNET

Paraganglioma, Pheochromocytoma, Carcinoma, Medullary, Neuroendocrine Tumors

NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Phase 2 Active not recruiting

20 enrolled

DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

NCT05263050 2026-05-22

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Phase 2 Recruiting

111 enrolled

EndocrineGenitourinaryNET

Clear-cell metastatic renal cell carcinoma, Carcinoid Tumor, Carcinoma, Renal Cell, Neuroendocrine Tumors

NCT06263088 2026-05-22

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Phase NA Recruiting

200 enrolled

EndocrineGastrointestinalNET

Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neuroendocrine Tumors

NCT06430021 2026-05-22

PRO-NEM1

Recruiting

297 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT06881992 2026-05-18

Tumor HI

Phase 3 Recruiting

16 enrolled

EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Clinical Trials

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

BCB RIV

CapTemY90

ReLUTH

LUPARPED

Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms

NET-COMPARE

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

PRO-NEM1

Tumor HI